Log in to your Inderes Free account to see all free content on this page.
Herantis Pharma
1.405 EUR -0.71%4,022 investors are following this company
Revenue
-
EBIT %
-
P/E
70.25
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Finland
HRTIS
Daily low / high price
1.4 / 1.405
EUR
Market cap
28.33M EUR
Turnover
4.2K EUR
Volume
3K
Latest videos
Financial calendar
General meeting
24.04.2024
Interim report
22.08.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Skandinaviska Enskilda Banken | 14.6 % | 14.6 % |
Joensuun kauppa ja kone Oy | 10.2 % | 10.2 % |
Premium
This content is for our Premium customers only.
Insider Transactions
Insider | Date | Total value |
---|---|---|
Tone Kvåle | 25.01.2024 | 7,500EUR |
Antti Vuolanto | 01.06.2022 | 1,200EUR |
Premium
This content is for our Premium customers only.
ShowingAll content types
Redeye: Herantis H2 2023 - Presented positive phase I data
Partnership agreements boost biotech funding in 2023
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio